Clinical trial

Real World Study With Benralizumab in Severe Asthma in Switzerland

NCT03907137

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2019-01-21

PhaseN/A

Study timeline

Study start (actual)2019-01-21Date precision: day

Registry last updated2024-02-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Severe Eosinophilic Asthmaunresolved

Interventions

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

ZurichSwitzerland3 BaselSwitzerland1 BernSwitzerland1 GenevaSwitzerland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03907137 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.